Form 4: Azenta Inc. Executive David Wang Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Azenta Inc. SVP & GM, SMS, David Wang, sold 348 shares of common stock to cover tax obligations related to vesting restricted stock units.
Summary
- David Wang, SVP & GM, SMS at Azenta, Inc., sold 348 shares of common stock on November 19, 2024.
- The sale was to cover withholding taxes associated with the vesting of 1,069 restricted stock units on November 15, 2024.
- The shares were sold at a weighted average price of $40.07, with individual sales ranging from $38.83 to $41.48 between November 18 and November 19, 2024.
- Following the transaction, Mr. Wang directly owns 24,114 shares of Azenta stock.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction for an executive to cover tax obligations, which is neither positive nor negative for the company's overall performance.
Industry Context
This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical executive stock sales for tax purposes.
- The sale of shares to cover tax obligations is a common practice among executives at publicly traded companies, including those in the life sciences and technology sectors, such as Thermo Fisher Scientific, Danaher, and Agilent Technologies.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale by an executive to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 11/15/2024 | Vesting date of 1,069 restricted stock units. |
| 11/18/2024 | Start date of the range of share sales. |
| 11/19/2024 | Date of the reported stock sale. |
| 11/21/2024 | Date of the Form 4 filing. |
Keywords
Azenta, David Wang, stock sale, insider trading, restricted stock units, tax obligations, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.